Navigation path

News Highlights

20 July 2017

Commission launches public consultation on Health and Care in the Digital Single Market

The European Commission launches a public consultation today on how Europe should promote digital innovation in health and care, for the benefits of citizens and of health systems in Europe. This consultation will help us to identify how to empower citizens, medical professionals and researchers; to ensure a right for citizens to have an electronic health record that they can access from everywhere in the EU, to improve prevention, rapid response to pandemic threats, personalised treatments and care.


19 July 2017

Innovative Medicines Initiative – new calls out

The Innovative Medicines Initiative has launched two Calls for proposals open, giving researchers from diverse sectors the opportunity to participate in ambitious public-private partnerships that will pave the way for the development of the medicines of the future. The deadline for both calls is 24 October 2017, 17:00, Brussels time.


29 June 2017

Antimicrobial Resistance: Commission steps us the fight with new Action Plan

The Commission continues to scale up its fight against antimicrobial resistance (AMR), with the launch of a second European Action Plan.

The new Action Plan is based on a One Health approach and focusses on supporting Member States, particularly in establishing, implementing and monitoring their National Action Plans. It also brings together EU funds and instruments to promote innovation and research against AMR and strengthen the EU's leading role in global fora, notably within the international organisations and with major trade partners.


20 June 2017

Launch of the African Access Initiative

The Initiative along with a white paper on cancer burden and emerging crisis in Africa, was launched at BIO 2017 in San Diego. Through the European and Developing Countries Clinical Trials Partnership (EDCTP), the European Commission has been actively involved in sub-Saharan Africa. EDCTP's objective in that area is to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases.


1 June 2017

€20 million EU loan to develop new device to quickly identify pathogens causing meningitis and other infectious diseases

An EU loan of €20 million will support a Barcelona-based start-up to develop and commercialise a device capable of identifying within an hour a range of infectious pathogens, such as those contained in meningitis, respiratory or gastro-intestinal infections. This loan is signed under the InnovFin Infectious Diseases Finance Facility.


5 April 2017

Katholieke Universiteit Leuven (KU Leuven) and partners developing dual vaccine against yellow fever and rabies, supported by Horizon 2020

The RABYD-VAX consortium, led by KU Leuven, is developing a cheap and easy-to-produce vaccine against rabies AND yellow fever which allows a stable temperature during transport and storage and thus guarantees a better efficiency compared to the existing vaccines.


3 April 2017

EMA publishes framework and action plan for closer interaction with academia

In the context of the European medicines regulatory network, the European Medicines Agency (EMA) has developed a framework and an action plan to reinforce collaboration with the academic community.


More News Headlines

 

 

Success Stories

Read more Success Stories

Upcoming Events

7-9 August 2017, Paris, France - 6th World Congress on Pharmacology

13-17 August 2017, Basel, Switzerland - WCS 2017 - World Congress of Surgery by ISS/SIC

More Events

Social Corner

twitter logo

Follow us on Twitter


Facebook logo Find us on Facebook on the EU Science & Innovation page page